For many people living in the U.S., the high retail costs of semaglutide (Ozempic and Wegovy) can reach $1,000+ per month without insurance coverage
Recent advancements in pathogenesis, diagnostics and treatment of alzheimers disease
The incretin arms suppress appetite and improve glucose control
Growth hormone peptides (CJC-1295, Ipamorelin, Sermorelin, MK-677) are best injected before bed to amplify the natural nocturnal GH pulse
The next wave of incretin-based therapies is poised to offer significant advantages over the current generation for treating diabetics and for weight loss in those living with obesity
The weight loss curve had not plateaued at 48 weeks, meaning longer treatment could produce even greater reductions